| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acalabrutinib for the initial treatment of chronic lymphocytic leukaemia
|
Davids, Matthew S
|
|
|
395 |
10232 |
p. 1234-1236
|
artikel
|
| 2 |
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial
|
Sharman, Jeff P
|
|
|
395 |
10232 |
p. 1278-1291
|
artikel
|
| 3 |
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial
|
Birtle, Alison
|
|
|
395 |
10232 |
p. 1268-1277
|
artikel
|
| 4 |
A new roadmap for meningitis
|
The Lancet,
|
|
|
395 |
10232 |
p. 1230
|
artikel
|
| 5 |
A risk-based approach is best for decision making on holding mass gathering events
|
McCloskey, Brian
|
|
|
395 |
10232 |
p. 1256-1257
|
artikel
|
| 6 |
Buruli ulcer: cured by 8 weeks of oral antibiotics?
|
Johnson, Paul D R
|
|
|
395 |
10232 |
p. 1231-1232
|
artikel
|
| 7 |
Cancer medicine: a missed opportunity
|
Devi, D Sita Ratna
|
|
|
395 |
10232 |
p. 1257-1258
|
artikel
|
| 8 |
COVID-19 exacerbating inequalities in the US
|
Dorn, Aaron van
|
|
|
395 |
10232 |
p. 1243-1244
|
artikel
|
| 9 |
COVID-19 in the USA: a question of time
|
The Lancet,
|
|
|
395 |
10232 |
p. 1229
|
artikel
|
| 10 |
Department of Error
|
|
|
|
395 |
10232 |
p. 1258
|
artikel
|
| 11 |
Effect of long-lasting insecticidal nets with and without piperonyl butoxide on malaria indicators in Uganda (LLINEUP): a pragmatic, cluster-randomised trial embedded in a national LLIN distribution campaign
|
Staedke, Sarah G
|
|
|
395 |
10232 |
p. 1292-1303
|
artikel
|
| 12 |
Essential care of critical illness must not be forgotten in the COVID-19 pandemic
|
Baker, Tim
|
|
|
395 |
10232 |
p. 1253-1254
|
artikel
|
| 13 |
Fangcang shelter hospitals: a novel concept for responding to public health emergencies
|
Chen, Simiao
|
|
|
395 |
10232 |
p. 1305-1314
|
artikel
|
| 14 |
Flooded by the torrent: the COVID-19 drug pipeline
|
Mullard, Asher
|
|
|
395 |
10232 |
p. 1245-1246
|
artikel
|
| 15 |
French research strategy to tackle antimicrobial resistance
|
Jouvin-Marche, Evelyne
|
|
|
395 |
10232 |
p. 1239-1241
|
artikel
|
| 16 |
Historical linkages: epidemic threat, economic risk, and xenophobia
|
White, Alexandre I R
|
|
|
395 |
10232 |
p. 1250-1251
|
artikel
|
| 17 |
John Frederick Murray
|
Watts, Geoff
|
|
|
395 |
10232 |
p. 1252
|
artikel
|
| 18 |
Medical student involvement in the COVID-19 response
|
|
|
|
395 |
10232 |
p. 1254
|
artikel
|
| 19 |
Medicine: before COVID-19, and after
|
McCartney, Margaret
|
|
|
395 |
10232 |
p. 1248-1249
|
artikel
|
| 20 |
Monitoring behavioural insights related to COVID-19
|
Betsch, Cornelia
|
|
|
395 |
10232 |
p. 1255-1256
|
artikel
|
| 21 |
Offline: CoHERE—a call for a post-pandemic health strategy
|
Horton, Richard
|
|
|
395 |
10232 |
p. 1242
|
artikel
|
| 22 |
Perpetuating gender inequity through uneven reporting
|
Cornell, Morna
|
|
|
395 |
10232 |
p. 1258
|
artikel
|
| 23 |
Pyrethroid resistance in sub-Saharan Africa
|
Bajunirwe, Francis
|
|
|
395 |
10232 |
p. 1236-1237
|
artikel
|
| 24 |
Refugee and migrant health in the COVID-19 response
|
Kluge, Hans Henri P
|
|
|
395 |
10232 |
p. 1237-1239
|
artikel
|
| 25 |
Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial
|
Phillips, Richard O
|
|
|
395 |
10232 |
p. 1259-1267
|
artikel
|
| 26 |
Sarah Gilbert: carving a path towards a COVID-19 vaccine
|
Lane, Richard
|
|
|
395 |
10232 |
p. 1247
|
artikel
|
| 27 |
Sustaining containment of COVID-19 in China
|
The Lancet,
|
|
|
395 |
10232 |
p. 1230
|
artikel
|
| 28 |
Treating hypoparathyroidism with recombinant human parathyroid hormone (1–34): long-term safety concerns
|
Goujard, Cécile
|
|
|
395 |
10232 |
p. 1304
|
artikel
|
| 29 |
Treatment of upper urinary tract urothelial carcinoma
|
Crabb, Simon J
|
|
|
395 |
10232 |
p. 1232-1234
|
artikel
|
| 30 |
Urgent dental care for patients during the COVID-19 pandemic
|
Dave, Manas
|
|
|
395 |
10232 |
p. 1257
|
artikel
|
Tijdschrift beschrijving